MyndTec (XCNQ:MYTC) Momentum Rank : 0 (As of Dec. 15, 2024)

View and export this data going back to 2022. Start your Free Trial

What is MyndTec Momentum Rank?

MyndTec has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

MyndTec Momentum Rank Related Terms

Thank you for viewing the detailed overview of MyndTec's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

MyndTec Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MyndTec Inc (XCNQ:MYTC) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

1900 Minnesota Court, Suite 122, Mississauga, ON, CAN, L5N 3C9

Website

https://www.myndtec.com

MyndTec Inc is a medical technology company. It researches, develops, and distributes new therapies designed to improve function, maximize independence and enhance the quality of life for individuals with upper limb paralysis due to stroke, spinal cord injury, or traumatic brain injury. The firm develops non-invasive neurological and nervous system electrical stimulation therapeutics for the treatment of neurological diseases and injuries specifically targeted to markets with large, growing, and patient populations. The company generates revenues from sales in Canada and the United States.

MyndTec Headlines

No Headlines